Last reviewed 2026-05-23 · How we verify

PUMACTANT

FDA-approved withdrawn Quality 6/100

PUMACTANT is a drug. It is currently FDA-approved.

At a glance

Generic name	PUMACTANT
Therapeutic area	Respiratory
Phase	FDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

PUMACTANT CI brief — competitive landscape report
PUMACTANT updates RSS · CI watch RSS

Frequently asked questions about PUMACTANT

What is PUMACTANT?

PUMACTANT is a pharmaceutical drug.

What development phase is PUMACTANT in?

PUMACTANT is FDA-approved (marketed).

Therapeutic area: All drugs in Respiratory

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing